U.S. markets open in 1 hour 51 minutes

Omeros Corporation (OMER)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
2.5500+0.0100 (+0.39%)
At close: 04:00PM EST
2.6000 +0.05 (+1.96%)
After hours: 07:48PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close2.5400
Bid2.3100 x 2900
Ask2.7900 x 1300
Day's Range2.2750 - 2.6189
52 Week Range0.9200 - 7.8000
Avg. Volume753,504
Market Cap160.307M
Beta (5Y Monthly)1.30
PE Ratio (TTM)N/A
EPS (TTM)-2.8900
Earnings DateNov 09, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est13.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for OMER

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Omeros Corporation
    Technical Assessment: Neutral in the Intermediate-TermWTI fell another 1% on Monday, closing at $73.27/barrel and near its November 16 closing low of $73.09. Crude oil is back near its lowest level since early July and has done a round trip from $70 to $95 and back again over the past five months. Oil just can't seem to get going in either direction, as it has traded between $64 and $95 since August 2022.
    Fair Value
    Economic Moat
    yesterdayArgus Research
View more
  • Insider Monkey

    Omeros Corporation (NASDAQ:OMER) Q3 2023 Earnings Call Transcript

    Omeros Corporation (NASDAQ:OMER) Q3 2023 Earnings Call Transcript November 10, 2023 Operator: Good afternoon, and welcome to today’s earnings call for Omeros Corporation. At this time, all participants are in a listen-only mode. After the company’s remarks, we will conduct a question-and-answer session. And please be advised that this call is being recorded at the […]

  • Thomson Reuters StreetEvents

    Q3 2023 Omeros Corp Earnings Call

    Q3 2023 Omeros Corp Earnings Call

  • Business Wire

    Omeros Corporation Reports Third Quarter 2023 Financial Results

    SEATTLE, November 09, 2023--Omeros Corporation (Nasdaq: OMER), a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders, today announced recent highlights and developments as well as financial results for the third quarter ended September 30, 2023, which in